yingweiwo

New1

New1

New1 related products

Structure Cat No. Product Name CAS No. Product Description
GSK1723980 V21822 GSK1723980 1244641-64-2 GSK1723980 is a novel and potent inhibitor of rTbIPMK
GSK172981 V21823 GSK172981 1133705-99-3 GSK172981 is a novel and potent non-peptide tachykinin NK3 receptor antagonist
GSK1733953A V21824 GSK1733953A 930470-97-6 DG70 (GSK1733953A) is a benzidine, a respiratory inhibitor of Mycobacterium tuberculosis (TB), inhibiting MenG activity with IC50 of 2.6 ± 0.6 μM.
GSK1795091 V21825 GSK1795091 1233589-81-5 GSK1795091 (CRX-601;GSK-1795091) is a novel and potent Toll-like receptor 4 (TLR4) agonist with antitumor activity.
GSK1829820A V21827 GSK1829820A 1443138-52-0 GSK1829820A is a novel and potent inhibitor of Mycobacterium tuberculosis H37Rv.
GSK1842799 V21828 GSK1842799 1005407-76-0 GSK1842799 is a novel and potent S1P1 receptor agonist
GSK199 V7968 GSK199 1549811-53-1 GSK199 is a reversible and selective PAD4 inhibitor (antagonist) with IC50 of 200 nM in the absence of calcium ions.
GSK1997132B V21829 GSK1997132B 1168138-37-1 GSK1997132B is a novel and potent PPARγ agonist
GSK2008607 V7676 GSK2008607 1244644-50-5 GSK2008607 is a novel and potent inhibitor of rTbIPMK
GSK2163632A V21832 GSK2163632A 1123163-20-1 GSK2163632A is a novel and potent insulin-like growth factor 1 receptor inhibitor
GSK2188764 V21833 GSK2188764 1849587-68-3 GSK2188764 is a novel and potent nhibitor of T.
GSK2210875 V21834 GSK2210875 1170668-67-3 GSK2210875 is a novel and potent mGluR5 antagonist
GSK223 V21835 GSK223 899758-61-3 GSK223 is a novel and potent inhibitor of IL-8
GSK2239633 V21836 GSK2239633 2181665-31-4 GSK2239633 (GSK-2239633) is a novel and potent CC-chemokine receptor 4 antagonist with anti-inflammatory activity.
GSK2245035 V21839 GSK2245035 1207629-49-9 GSK2245035 (GSK-2245035) is a novel potent andselective intranasalToll-like receptor 7 (TLR7) agonistwith Type-1 interferon (IFN)-stimulating activity and the potential to be used for the treatment of asthma.
GSK2256294 HCl V21841 GSK2256294 HCl GSK2256294 HCl is a novel and potent inhibitor of sEH
GSK2263167 V21843 GSK2263167 1165924-28-6 GSK2263167 is an S1P1 receptor agonist (activator).
GSK2324 V21432 GSK2324 1020567-30-9 GSK2324 (GSK-2324) is a novel and potent FXR agonist that has the potentialto treat non-alcoholic fatty liver disease (NAFLD), in part because they reducehepatic lipids.
GSK256073 V21849 GSK256073 802892-90-8 GSK256073 is a potent, selective, orally bioactive GPR109A agonist and a durable HCA2 agonist with pEC50 of 7.5 (Human HCA2).
GSK256073 V21848 GSK256073 862892-90-8 GSK256073 is a potent, selective, orally bioactive GPR109A agonist and a durable HCA2 agonist with pEC50 of 7.5 (Human HCA2).
Contact Us